prostatic neoplasms

Research Reports

PSA Outcomes and Clinical Surveillance Among Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With a Next-Generation Androgen Receptor Inhibitor in Urology Practices With or Without In-Office Dispensing

06/03/2024

Sabree C. Burbage, PharmD

Dexter Waters, MSPH

Carmine Rossi, PhD

Frederic Kinkead, MA

Erik Muser, PharmD

Lorie Ellis, PhD

Patrick Lefebvre, MA

Dominic Pilon, MA

This study describes prostate-specific antigen (PSA) outcomes and clinical surveillance patterns among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) receiving next-generation androgen receptor inhibitors (ARIs)...

This study describes...

06/03/2024

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

September 18 ⁠–⁠ September 20

September 20 ⁠–⁠ September 22

September 21 ⁠–⁠ September 22

September 30 ⁠–⁠ October 2

October 1 ⁠–⁠ October 2

October 2 ⁠–⁠ October 5

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

See Full Calendar

prostatic neoplasms

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products